Trial intelligence / Profile preview

Emblica Officinalis vs 3% Sodium Hypochlorite as Root Canal Irrigants

NCT07688005Not yet recruiting

Sponsor
Postgraduate Medical Institute
Start
Sep 2026
Primary completion
Nov 2026
Countries
1
01

Overview

Randomised trial of phyllanthus emblica in pulp necrosis and apical periodontitis (AP) (2 arms), sponsored by Postgraduate Medical Institute. Primary endpoint: Reduction in Enterococcus faecalis bacterial count at 7 days. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

phyllanthus emblica
03

Conditions

pulp necrosisapical periodontitis (AP)

Beyond the preview

Go deeper on NCT07688005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07688005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call